Patient subtypes: real or not?
•
1 like•282 views
The document discusses the challenges of using clustering methods to identify patient subtypes or clusters. It notes that while every dataset contains clusters, not all identified clusters are necessarily real, interesting, or meaningful. It provides examples of diabetes and asthma clustering studies and questions whether the identified clusters are truly valid given issues like dataset dimensionality, choice of clustering algorithm, and lack of validation across multiple datasets. The key takeaway is that clustering generates hypotheses about subgroups that require rigorous validation before clusters can be considered real and useful.
Report
Share
Report
Share
Download to read offline
Recommended
Reference Letter - Varinder Pandher
Varinder worked as a summer research assistant for Emily Heath at Ryerson University in 2013. His project involved simulating needle deflections during prostate brachytherapy cancer treatment to determine which deflection scenarios predicted the clinically delivered treatment dose. Emily found Varinder to be polite, motivated, and interested in medical physics. He demonstrated proficiency with MATLAB for his research project, which generated results helpful to Emily's continued work in this area.
Response heterigeneity and Replicated Crossover Trials
These slides are based on those I presented at the recent Physiological Society Symposium, but without any recorded narration.
Choosing Regression Models
This document provides an introduction to choosing regression models. It discusses basic considerations like determining the purpose of the model, choosing appropriate predictors, and whether predictors or the outcome need transformation. Temporal sequence and prior knowledge are important factors in choosing predictors. The type of data, case ascertainment, and results of model fitting also influence predictor choice. Transforming predictors or the outcome can improve the model fit in some cases. The key is using statistical tools together with experience and understanding, not as a substitute for scientific insight.
2010 smg training_cardiff_day1_session1(2 of 3) altman
This document discusses approaches for conducting meta-analyses of skewed continuous data where studies report outcomes using different metrics such as means, medians, and ranges. It recommends converting outcomes reported as medians or ranges into means and standard deviations on the log scale before combining, assuming the data are approximately lognormal. It also describes using the method of Higgins et al. (2008) to combine statistics reported on both raw and log-transformed scales. References are provided for methods converting ranges to means and standard deviations and for an example application in a Cochrane review.
Sample size calculation - Animal experimentation
Nowadays Scientists using laboratory animals are under increasing pressure to justify their sample sizes using a ‘‘power analysis’’ to improve study reproducibility and from ethical point of view too.
In this presentation, I review the three methods currently used to determine sample size: ‘‘tradition’’ or ‘‘common sense’’, the ‘‘resource equation’’ and the ‘‘power analysis’’.
The challenge of small data
1) The document discusses the challenge of studying rare diseases due to the small amount of available data. It proposes that N-of-1 trials, where individual patients are repeatedly randomized to treatment or control, could help address this issue.
2) It provides examples of how careful experimental design and statistical analysis are important even with small data sets. Factors like randomization, blocking, and replication can increase efficiency and validity.
3) Analyzing an N-of-1 trial for a rare disease, the document explores objectives like determining if one treatment is better, estimating average effects, and predicting effects for future patients. It discusses randomization and sampling philosophies and mixed effects models.
P-values the gold measure of statistical validity are not as reliable as many...
This is an article that appeared in the NATURE as News Feature dated 12-February-2014. This article was presented in the journal club at Oman Medical College , Bowshar Campus on December, 17, 2015. This article was presented by Pratap David , Biostatistics Lecturer.
Vaccine trials in the age of COVID-19
The response to the COVID-19 crisis by various vaccine developers has been extraordinary, both in terms of speed of response and the delivered efficacy of the vaccines. It has also raised some fascinating issues of design, analysis and interpretation. I shall consider some of these issues, taking as my example, five vaccines: Pfizer/BioNTech, AstraZeneca/Oxford, Moderna, Novavax, and J&J Janssen but concentrating mainly on the first two. Among matters covered will be concurrent control, efficient design, issues of measurement raised by two-shot vaccines and implications for roll-out, and the surprising effectiveness of simple analyses. Differences between the five development programmes as they affect statistics will be covered but some essential similarities will also be discussed.
Recommended
Reference Letter - Varinder Pandher
Varinder worked as a summer research assistant for Emily Heath at Ryerson University in 2013. His project involved simulating needle deflections during prostate brachytherapy cancer treatment to determine which deflection scenarios predicted the clinically delivered treatment dose. Emily found Varinder to be polite, motivated, and interested in medical physics. He demonstrated proficiency with MATLAB for his research project, which generated results helpful to Emily's continued work in this area.
Response heterigeneity and Replicated Crossover Trials
These slides are based on those I presented at the recent Physiological Society Symposium, but without any recorded narration.
Choosing Regression Models
This document provides an introduction to choosing regression models. It discusses basic considerations like determining the purpose of the model, choosing appropriate predictors, and whether predictors or the outcome need transformation. Temporal sequence and prior knowledge are important factors in choosing predictors. The type of data, case ascertainment, and results of model fitting also influence predictor choice. Transforming predictors or the outcome can improve the model fit in some cases. The key is using statistical tools together with experience and understanding, not as a substitute for scientific insight.
2010 smg training_cardiff_day1_session1(2 of 3) altman
This document discusses approaches for conducting meta-analyses of skewed continuous data where studies report outcomes using different metrics such as means, medians, and ranges. It recommends converting outcomes reported as medians or ranges into means and standard deviations on the log scale before combining, assuming the data are approximately lognormal. It also describes using the method of Higgins et al. (2008) to combine statistics reported on both raw and log-transformed scales. References are provided for methods converting ranges to means and standard deviations and for an example application in a Cochrane review.
Sample size calculation - Animal experimentation
Nowadays Scientists using laboratory animals are under increasing pressure to justify their sample sizes using a ‘‘power analysis’’ to improve study reproducibility and from ethical point of view too.
In this presentation, I review the three methods currently used to determine sample size: ‘‘tradition’’ or ‘‘common sense’’, the ‘‘resource equation’’ and the ‘‘power analysis’’.
The challenge of small data
1) The document discusses the challenge of studying rare diseases due to the small amount of available data. It proposes that N-of-1 trials, where individual patients are repeatedly randomized to treatment or control, could help address this issue.
2) It provides examples of how careful experimental design and statistical analysis are important even with small data sets. Factors like randomization, blocking, and replication can increase efficiency and validity.
3) Analyzing an N-of-1 trial for a rare disease, the document explores objectives like determining if one treatment is better, estimating average effects, and predicting effects for future patients. It discusses randomization and sampling philosophies and mixed effects models.
P-values the gold measure of statistical validity are not as reliable as many...
This is an article that appeared in the NATURE as News Feature dated 12-February-2014. This article was presented in the journal club at Oman Medical College , Bowshar Campus on December, 17, 2015. This article was presented by Pratap David , Biostatistics Lecturer.
Vaccine trials in the age of COVID-19
The response to the COVID-19 crisis by various vaccine developers has been extraordinary, both in terms of speed of response and the delivered efficacy of the vaccines. It has also raised some fascinating issues of design, analysis and interpretation. I shall consider some of these issues, taking as my example, five vaccines: Pfizer/BioNTech, AstraZeneca/Oxford, Moderna, Novavax, and J&J Janssen but concentrating mainly on the first two. Among matters covered will be concurrent control, efficient design, issues of measurement raised by two-shot vaccines and implications for roll-out, and the surprising effectiveness of simple analyses. Differences between the five development programmes as they affect statistics will be covered but some essential similarities will also be discussed.
Kay Dickersin
The document discusses how to determine when randomized controlled trial (RCT) data is sufficient to address effectiveness and harm or when more information is needed, noting that the appropriate type of evidence depends on how the question is classified and that observational data can sometimes supplement what is known from RCTs. It also addresses questions about interpreting trial results from narrow populations, balancing benefits and harms across groups, communicating findings without jargon, detecting biased trial designs, and assessing adaptive trial designs.
Comparing research designs fw 2013 handout version
This is an updated version of my Comparing Research Designs lecture, which now includes discussions on: (1) common considerations with research design such as bias, reliability, validity, and confounding; and (2) expanded discussion of RCT designs including factorial and cross-over designs.
How to critique articles
The document provides guidance on how to critique scientific articles. It discusses evaluating the study design, methodology, population, interventions, outcomes, and statistics. Key aspects to examine include the randomization and blinding methods, comparison groups, sample sizes, narrowness of focus, and appropriate application of statistical tests. The goal is to determine if the evidence presented is sufficient to accept the study's conclusions by considering factors like biases, generalizability, and clinical significance of any findings.
Stats Workshop2010
1. The document introduces statistical analysis and the scientific method, including deductive and inductive reasoning approaches.
2. It discusses experimental design, observational studies, and the importance of gathering sufficient data to draw meaningful conclusions.
3. Guidelines are provided for statistical analysis techniques including summarizing data, forming hypotheses to test, and using common fundamental methods such as t-tests, regression, and analysis of variance.
Critical appraisal 2012 updated
This document provides an introduction to critical appraisal. It defines critical appraisal as systematically weighing the quality and relevance of research to inform decision making. The document outlines different types of research studies including systematic reviews, randomized controlled trials, cohort studies, and case-control studies. It discusses how to critically appraise studies by assessing their validity, results, and relevance. Key aspects of appraising randomized controlled trials are described such as randomization, blinding, accounting for all participants, and interpreting results including p-values and confidence intervals. The goal is to help readers gain skills to critically evaluate research.
Introduction to Systematic Review & Meta-Analysis
The document discusses systematic reviews and meta-analyses. It defines systematic reviews as a summary of available healthcare studies that provides high-level evidence on healthcare interventions. Meta-analyses use statistical methods to quantitatively summarize results across multiple studies. The document outlines the steps in conducting systematic reviews, including developing a protocol, searching for evidence, assessing risk of bias, and synthesizing findings. It also discusses how meta-analyses can help determine the strength and consistency of effects across studies.
The Research Process
This document summarizes a statistics lecture about the research process and why statistics are needed in optometry and vision science. It discusses the steps of evidence-based practice including asking questions, acquiring evidence, appraising evidence, and applying evidence. It also covers generating and testing theories, levels of measurement, measurement error, validity, reliability, types of research such as correlational and experimental research, and methods of data collection and analysis. The goal is to explain the research process and why statistics are an essential tool for evidence-based practice in optometry.
David Moher - MedicReS World Congress 2012
This document discusses sources of bias in medical research and means to assess bias. It acknowledges the Cochrane Collaboration's Bias Methods Group and provides an overview of the impact of bias. Sources of bias can occur in the production and dissemination of evidence, including reporting biases like publication bias. Meta-epidemiological studies have found empirical evidence of biases in randomized controlled trials. Methods have been developed to assess bias in primary studies. While registration of clinical trials and systematic review protocols are attempts to minimize bias, bias remains an issue and further efforts are still needed.
Introduction to evidence based practice slp6030
This document discusses evidence-based practice in speech-language pathology. It defines evidence-based practice as integrating clinical expertise, patient values, and the best research evidence. Lower levels of research evidence are still useful if they are the best available. Treatment efficacy focuses on controlled studies while effectiveness looks at outcomes under typical clinical conditions. Clinicians should have an open and honest approach when considering different treatment options and be guided by principles of beneficence, autonomy, nonmaleficence, and justice. Forming answerable clinical questions is important to evidence-based practice.
Evidence based psychiatry
This document provides an overview of evidence-based psychiatry. It defines evidence-based medicine and outlines the key steps, including formulating an answerable clinical question using PICO, finding the best evidence, appraising the evidence, and applying it to individual patients. The document discusses different types of studies and how to evaluate their results, focusing on sensitivity, specificity, odds ratios, and other statistical concepts. It emphasizes integrating individual clinical expertise with the best available external evidence.
Statistical errors can cause deaths
Statistical errors can not be ignored. They have the potential to jeopardize life and health of many people.
Type of randomization
Randomization aims to equally distribute participant characteristics between treatment groups to prevent bias. There are several types of randomization including simple, block, and stratified block randomization. Blinding, such as double or triple blinding, helps prevent performance, detection, and other biases by keeping parties unaware of treatment assignments. Bias can still occur through factors like selection, performance, detection, laboratory, or sample size biases if randomization and blinding are not properly implemented.
The ClinGen Sequence Variant Interpretation Working Group: Refining Criteria ...
The ClinGen Sequence Variant Interpretation Working Group: Refining Criteria ...Human Variome Project
The ClinGen Sequence Variant Interpretation Working Group aims to refine criteria for classifying genetic variants by standardizing how different types of evidence are integrated. In the short term, it will refine and modify current American College of Medical Genetics guidelines. It will work with disease-specific groups to evaluate criteria like population frequency thresholds and computational methods. The long term goal is to develop a quantitative Bayesian framework to classify variants. The working group will analyze ClinVar to identify disease genes with many reported variants to help evaluate criteria.Study designs 2013
This document provides an overview of different study designs used in epidemiology and biomedical research. It begins by distinguishing between observational and experimental studies. The main types of observational studies covered are case-control, cohort, cross-sectional, and ecological studies. Experimental studies discussed are randomized controlled trials. Key characteristics, advantages, and disadvantages of each study design are outlined. Examples are provided to illustrate concepts.
American Association for Suicidology (2020), Jaspr Health (DIMEFF)
This document summarizes research on using a digital tool called Jaspr to provide suicide prevention for adults in crisis in emergency departments. An observational study of 82 individuals found that Jaspr effectively delivered best practices like safety planning and helped reduce distress. A randomized controlled trial of 31 individuals found that those using Jaspr received more thorough best practices and had significantly lower distress and higher satisfaction than standard care. The tool integrates both scientific and lived experience expertise to transform emergency suicide care delivery.
Digital transformation of translational medicine
Anthony Finbow, Executive Chairman, and William Spooner, Chief Science Officer, discuss Eagle Genomics' software product, marketed at pharmaceutical and biotech companies, which enables radical improvements in the productivity of scientific research.
Reading & Understanding Medical Studies -- On Deadline
Health and science journalists reporting on medical studies need to understand the parts of a study, ways to report results, how to assess whether a study is worth covering, and the difference between relative and absolute risk.
Search the literature: the beginning
This document provides guidance on searching the literature for health information. It recommends planning searches by focusing questions, breaking them into basic terms, and choosing appropriate research methods and databases. Searches can be refined using Boolean operators like AND, OR and NOT to combine search terms. Higher levels of evidence include systematic reviews and randomized controlled trials. The document encourages contacting librarians for assistance if searches take more than 10 minutes.
"How Scientific Wellness will Drive The Future of Health" - Nathan Price (Pro...
"How Scientific Wellness will Drive The Future of Health" - Nathan Price (Professor, Institute of Systems Biology)
Delivered at the inaugural Hyper Wellbeing Summit, 14th November 2016, Mountain View, California.
For more information including details of subsequent events, please visit http://hyperwellbeing.com
The summit was created to foster a community around an emerging industry - Wellness as a Service (WaaS). Consumer technologies, in particular wearables and mobile, are powering a consumer revolution. A revolution to turn health and wellness into platform delivered services. A revolution enabling consumer data-driven disease risk reduction. A revolution extending health care past sick care towards consumer-led lifelong health, wellness and lifestyle optimization.
WaaS newsletter sign-up http://eepurl.com/b71fdr
@hyperwellbeing
Coursebooklet
This document provides an overview of essentials for manuscript review, including how to organize a manuscript, use statistics, identify types of studies and levels of evidence, address bias, interpret results, and write an abstract, introduction, methods, discussion, and conclusion. It discusses key aspects of each section and how to effectively review a submitted manuscript.
Can drug repurposing be saved with AI 202405.pdf
Presented at DigiTechPharma, London May 2024.
What is drug repurposing. Why is it needed? What systematic approaches are there? Is AI a solution? Why not?
IA, la clave de la genomica (May 2024).pdf
A.k.a. AI, the key to genomics. Presented at 1er Congreso Español de Medicina Genómica. Spanish language.
On the failure of applied genomics. On the complexity of genomics, biology, medicine. The need for AI. Barriers.
More Related Content
Similar to Patient subtypes: real or not?
Kay Dickersin
The document discusses how to determine when randomized controlled trial (RCT) data is sufficient to address effectiveness and harm or when more information is needed, noting that the appropriate type of evidence depends on how the question is classified and that observational data can sometimes supplement what is known from RCTs. It also addresses questions about interpreting trial results from narrow populations, balancing benefits and harms across groups, communicating findings without jargon, detecting biased trial designs, and assessing adaptive trial designs.
Comparing research designs fw 2013 handout version
This is an updated version of my Comparing Research Designs lecture, which now includes discussions on: (1) common considerations with research design such as bias, reliability, validity, and confounding; and (2) expanded discussion of RCT designs including factorial and cross-over designs.
How to critique articles
The document provides guidance on how to critique scientific articles. It discusses evaluating the study design, methodology, population, interventions, outcomes, and statistics. Key aspects to examine include the randomization and blinding methods, comparison groups, sample sizes, narrowness of focus, and appropriate application of statistical tests. The goal is to determine if the evidence presented is sufficient to accept the study's conclusions by considering factors like biases, generalizability, and clinical significance of any findings.
Stats Workshop2010
1. The document introduces statistical analysis and the scientific method, including deductive and inductive reasoning approaches.
2. It discusses experimental design, observational studies, and the importance of gathering sufficient data to draw meaningful conclusions.
3. Guidelines are provided for statistical analysis techniques including summarizing data, forming hypotheses to test, and using common fundamental methods such as t-tests, regression, and analysis of variance.
Critical appraisal 2012 updated
This document provides an introduction to critical appraisal. It defines critical appraisal as systematically weighing the quality and relevance of research to inform decision making. The document outlines different types of research studies including systematic reviews, randomized controlled trials, cohort studies, and case-control studies. It discusses how to critically appraise studies by assessing their validity, results, and relevance. Key aspects of appraising randomized controlled trials are described such as randomization, blinding, accounting for all participants, and interpreting results including p-values and confidence intervals. The goal is to help readers gain skills to critically evaluate research.
Introduction to Systematic Review & Meta-Analysis
The document discusses systematic reviews and meta-analyses. It defines systematic reviews as a summary of available healthcare studies that provides high-level evidence on healthcare interventions. Meta-analyses use statistical methods to quantitatively summarize results across multiple studies. The document outlines the steps in conducting systematic reviews, including developing a protocol, searching for evidence, assessing risk of bias, and synthesizing findings. It also discusses how meta-analyses can help determine the strength and consistency of effects across studies.
The Research Process
This document summarizes a statistics lecture about the research process and why statistics are needed in optometry and vision science. It discusses the steps of evidence-based practice including asking questions, acquiring evidence, appraising evidence, and applying evidence. It also covers generating and testing theories, levels of measurement, measurement error, validity, reliability, types of research such as correlational and experimental research, and methods of data collection and analysis. The goal is to explain the research process and why statistics are an essential tool for evidence-based practice in optometry.
David Moher - MedicReS World Congress 2012
This document discusses sources of bias in medical research and means to assess bias. It acknowledges the Cochrane Collaboration's Bias Methods Group and provides an overview of the impact of bias. Sources of bias can occur in the production and dissemination of evidence, including reporting biases like publication bias. Meta-epidemiological studies have found empirical evidence of biases in randomized controlled trials. Methods have been developed to assess bias in primary studies. While registration of clinical trials and systematic review protocols are attempts to minimize bias, bias remains an issue and further efforts are still needed.
Introduction to evidence based practice slp6030
This document discusses evidence-based practice in speech-language pathology. It defines evidence-based practice as integrating clinical expertise, patient values, and the best research evidence. Lower levels of research evidence are still useful if they are the best available. Treatment efficacy focuses on controlled studies while effectiveness looks at outcomes under typical clinical conditions. Clinicians should have an open and honest approach when considering different treatment options and be guided by principles of beneficence, autonomy, nonmaleficence, and justice. Forming answerable clinical questions is important to evidence-based practice.
Evidence based psychiatry
This document provides an overview of evidence-based psychiatry. It defines evidence-based medicine and outlines the key steps, including formulating an answerable clinical question using PICO, finding the best evidence, appraising the evidence, and applying it to individual patients. The document discusses different types of studies and how to evaluate their results, focusing on sensitivity, specificity, odds ratios, and other statistical concepts. It emphasizes integrating individual clinical expertise with the best available external evidence.
Statistical errors can cause deaths
Statistical errors can not be ignored. They have the potential to jeopardize life and health of many people.
Type of randomization
Randomization aims to equally distribute participant characteristics between treatment groups to prevent bias. There are several types of randomization including simple, block, and stratified block randomization. Blinding, such as double or triple blinding, helps prevent performance, detection, and other biases by keeping parties unaware of treatment assignments. Bias can still occur through factors like selection, performance, detection, laboratory, or sample size biases if randomization and blinding are not properly implemented.
The ClinGen Sequence Variant Interpretation Working Group: Refining Criteria ...
The ClinGen Sequence Variant Interpretation Working Group: Refining Criteria ...Human Variome Project
The ClinGen Sequence Variant Interpretation Working Group aims to refine criteria for classifying genetic variants by standardizing how different types of evidence are integrated. In the short term, it will refine and modify current American College of Medical Genetics guidelines. It will work with disease-specific groups to evaluate criteria like population frequency thresholds and computational methods. The long term goal is to develop a quantitative Bayesian framework to classify variants. The working group will analyze ClinVar to identify disease genes with many reported variants to help evaluate criteria.Study designs 2013
This document provides an overview of different study designs used in epidemiology and biomedical research. It begins by distinguishing between observational and experimental studies. The main types of observational studies covered are case-control, cohort, cross-sectional, and ecological studies. Experimental studies discussed are randomized controlled trials. Key characteristics, advantages, and disadvantages of each study design are outlined. Examples are provided to illustrate concepts.
American Association for Suicidology (2020), Jaspr Health (DIMEFF)
This document summarizes research on using a digital tool called Jaspr to provide suicide prevention for adults in crisis in emergency departments. An observational study of 82 individuals found that Jaspr effectively delivered best practices like safety planning and helped reduce distress. A randomized controlled trial of 31 individuals found that those using Jaspr received more thorough best practices and had significantly lower distress and higher satisfaction than standard care. The tool integrates both scientific and lived experience expertise to transform emergency suicide care delivery.
Digital transformation of translational medicine
Anthony Finbow, Executive Chairman, and William Spooner, Chief Science Officer, discuss Eagle Genomics' software product, marketed at pharmaceutical and biotech companies, which enables radical improvements in the productivity of scientific research.
Reading & Understanding Medical Studies -- On Deadline
Health and science journalists reporting on medical studies need to understand the parts of a study, ways to report results, how to assess whether a study is worth covering, and the difference between relative and absolute risk.
Search the literature: the beginning
This document provides guidance on searching the literature for health information. It recommends planning searches by focusing questions, breaking them into basic terms, and choosing appropriate research methods and databases. Searches can be refined using Boolean operators like AND, OR and NOT to combine search terms. Higher levels of evidence include systematic reviews and randomized controlled trials. The document encourages contacting librarians for assistance if searches take more than 10 minutes.
"How Scientific Wellness will Drive The Future of Health" - Nathan Price (Pro...
"How Scientific Wellness will Drive The Future of Health" - Nathan Price (Professor, Institute of Systems Biology)
Delivered at the inaugural Hyper Wellbeing Summit, 14th November 2016, Mountain View, California.
For more information including details of subsequent events, please visit http://hyperwellbeing.com
The summit was created to foster a community around an emerging industry - Wellness as a Service (WaaS). Consumer technologies, in particular wearables and mobile, are powering a consumer revolution. A revolution to turn health and wellness into platform delivered services. A revolution enabling consumer data-driven disease risk reduction. A revolution extending health care past sick care towards consumer-led lifelong health, wellness and lifestyle optimization.
WaaS newsletter sign-up http://eepurl.com/b71fdr
@hyperwellbeing
Coursebooklet
This document provides an overview of essentials for manuscript review, including how to organize a manuscript, use statistics, identify types of studies and levels of evidence, address bias, interpret results, and write an abstract, introduction, methods, discussion, and conclusion. It discusses key aspects of each section and how to effectively review a submitted manuscript.
Similar to Patient subtypes: real or not? (20)
Comparing research designs fw 2013 handout version
Comparing research designs fw 2013 handout version
The ClinGen Sequence Variant Interpretation Working Group: Refining Criteria ...
The ClinGen Sequence Variant Interpretation Working Group: Refining Criteria ...
American Association for Suicidology (2020), Jaspr Health (DIMEFF)
American Association for Suicidology (2020), Jaspr Health (DIMEFF)
Reading & Understanding Medical Studies -- On Deadline
Reading & Understanding Medical Studies -- On Deadline
"How Scientific Wellness will Drive The Future of Health" - Nathan Price (Pro...
"How Scientific Wellness will Drive The Future of Health" - Nathan Price (Pro...
More from Paul Agapow
Can drug repurposing be saved with AI 202405.pdf
Presented at DigiTechPharma, London May 2024.
What is drug repurposing. Why is it needed? What systematic approaches are there? Is AI a solution? Why not?
IA, la clave de la genomica (May 2024).pdf
A.k.a. AI, the key to genomics. Presented at 1er Congreso Español de Medicina Genómica. Spanish language.
On the failure of applied genomics. On the complexity of genomics, biology, medicine. The need for AI. Barriers.
Digital Biomarkers, a (too) brief introduction.pdf
Presentation at the Artid workshop, U. Bristol, March 2024, on digital biomarkers for improved clinical trials and monitoring of complex diseases, including neurological & movement disorders.
How to make every mistake and still have a career, Feb2024.pdf
Brief talk given at Edinburgh University for careers service, looking at career development for data-centric graduates
ML, biomedical data & trust
Journal club and talk given to Health Data Analytics MSc, February 2023. Reflecting on how to do good machine learning over biomedical data, the pitfalls and good practices
Where AI will (and won't) revolutionize biomedicine
The document discusses opportunities and challenges for using AI and machine learning in biomedicine and drug development. It notes that while biology and physiology are highly complex, images and other medical data are well-suited for computer analysis. However, collecting and standardizing appropriate data remains a challenge. Additionally, there is sometimes a disconnect between AI research and real-world medical needs. Overall, the document argues that AI could help with tasks like disease classification, drug target identification, and interpreting medical images, but developing effective applications requires addressing issues of data availability and model validation.
Beyond Proofs of Concept for Biomedical AI
This document discusses challenges with applying machine learning and AI to healthcare and biomedicine. It summarizes that while AI promises improvements, many projects fail to deliver due to issues like focusing on the wrong problems, lack of data, and lack of collaboration between fields. It advocates for approaches like validating and reproducing results, ensuring interpretability, collaborating across expertise, and focusing on incremental improvements rather than novel methods alone.
Multi-omics for drug discovery: what we lose, what we gain
This document discusses how multi-omics approaches could be used in drug development to address challenges arising from complex disease biology. It notes that drug development is becoming slower and more expensive as biological understanding lags behind, and that multi-omics allows integrated analysis across different biological data types and levels. Examples are given showing how multi-omics has been applied to cancer prediction and stratification using various data, asthma subtyping, drug repurposing using knowledge graphs, and predicting adverse drug events. The document emphasizes that careful methodology is still needed and highlights challenges including data integration and sample size.
ML & AI in pharma: an overview
Presented at LT (Laboratory Technology) CON 21. A brief overview of the possibilities and obstacles for ML in drug development
ML & AI in Drug development: the hidden part of the iceberg
This document summarizes the challenges of applying machine learning and artificial intelligence to drug development. It discusses how drug development is a long and complex process involving identifying disease targets, developing drug candidates, and testing through clinical trials. It then explains that biology is complex, data is often incomplete or biased, and there is a lack of labeled examples, making application of AI difficult. However, areas that could benefit include using AI to subtype diseases, interpret medical images like tumors, and build knowledge graphs to discover new insights. More and better quality data, along with focus on interpretability and engineering practices, are needed to further progress in this area.
Machine learning, health data & the limits of knowledge
Lecture for Imperial College London's MSc in Health Data Analytics, critiquing a recent paper on COVID diagnosis and moving out to talk about good practices (& limits) in ML and model building
AI in Healthcare
The document discusses how AI and machine learning can help address challenges in healthcare by analyzing complex medical data. It provides examples of how AI can help with tasks like analyzing medical images to assist radiologists, predicting drug response from scans, and using electronic health records to better understand diseases and patient heterogeneity. The document also acknowledges challenges like the need for large labeled datasets and ensuring interpretability and avoidance of bias.
The End of the Drug Development Casino?
D4 keynote October 2020
How Machine Learning, RWE and Data Science might tilt the odds in the drug development pipeline and how we should go about it
Get yourself a better bioinformatics job
This document provides career advice for bioinformaticians seeking better jobs or career advancement. It outlines several "rules" including being clear on one's career goals, actively pursuing opportunities rather than waiting passively, viewing one's career path as non-linear, emphasizing valuable skills over job titles, regularly pursuing new opportunities, networking to increase visibility, optimizing one's resume, and negotiating salary offers. The document encourages bioinformaticians to be proactive and flexible in managing their careers.
Interpreting Complex Real World Data for Pharmaceutical Research
This document discusses using real world data (RWD) for pharmaceutical research and development. It notes that while RWD is attractive due to its scale and realism, it is also complex and difficult to interpret. The document proposes several approaches for analyzing RWD, including using machine learning on graphical representations of patient data, analyzing temporal trajectories, integrating multiple 'omics data sources, and generating hypotheses rather than attempting to definitively model patient populations. It concludes that more work is needed to build larger, more diverse real world datasets and address challenges around privacy, methods validation, and scaling analysis techniques.
Filling the gaps in translational research
- Translational research often focuses on early-stage problems that are interesting scientifically but do not address the most important problems in developing new therapies. This neglects later and more difficult stages of drug development where the largest costs and failures occur.
- More focus is needed on developing therapies for complex, systemic diseases and diverse patient populations using real-world data and approaches that incorporate biological complexity early in the process. Machine learning should be applied where it can have the most impact in reducing costs, such as predicting adverse events later in development.
- Efforts are also needed to build more diverse, representative datasets and use data science approaches like drug repurposing that have the potential to accelerate therapy development.
Bioinformatics! (What is it good for?)
This document discusses various topics related to bioinformatics including data analysis tools, thresholds, gene expression analysis, precision medicine, code quality, and standards. It thanks several people for their contributions to the field of bioinformatics.
Big Data & ML for Clinical Data
Big Data and machine learning are increasingly important in biomedical science and clinical practice. Big Data refers to large and complex datasets that are too large for traditional tools to handle. Machine learning involves algorithms that can recognize patterns in data without being explicitly programmed. Some challenges of working with big data and machine learning include issues with data volume, variety, and veracity. However, techniques like distributed analysis, standards, and validation can help address these challenges.
Machine Learning for Preclinical Research
This document summarizes a presentation on machine learning for preclinical research. It discusses how biomedical data sets are often small and discusses challenges in applying deep learning and other machine learning techniques with limited data. It proposes combining multiple smaller datasets using standards to create larger datasets for analysis. The document also notes issues with noise and bias in biomedical data and proposes careful curation and appropriate analysis methods. In conclusion, it advocates for carefully curated combined datasets, integrating different data types and sources, and validated application of machine learning to support preclinical research.
AI for Precision Medicine (Pragmatic preclinical data science)
This document summarizes a presentation on using data science approaches like machine learning for precision medicine and biomedical research. It notes that biomedical data sets are often small, which limits the use of deep learning techniques that require large amounts of labeled data. It advocates combining multiple smaller datasets together using standards to create larger datasets for analysis. It also emphasizes using multiple data types (e.g. omics data, electronic health records, social media) together through integrated analysis to provide more context than any single data type alone. It provides examples of applying these approaches to problems like classifying texts for systematic reviews and discovering asthma subtypes through multi-omics analysis.
More from Paul Agapow (20)
Digital Biomarkers, a (too) brief introduction.pdf
Digital Biomarkers, a (too) brief introduction.pdf
How to make every mistake and still have a career, Feb2024.pdf
How to make every mistake and still have a career, Feb2024.pdf
Where AI will (and won't) revolutionize biomedicine
Where AI will (and won't) revolutionize biomedicine
Multi-omics for drug discovery: what we lose, what we gain
Multi-omics for drug discovery: what we lose, what we gain
ML & AI in Drug development: the hidden part of the iceberg
ML & AI in Drug development: the hidden part of the iceberg
Machine learning, health data & the limits of knowledge
Machine learning, health data & the limits of knowledge
Interpreting Complex Real World Data for Pharmaceutical Research
Interpreting Complex Real World Data for Pharmaceutical Research
AI for Precision Medicine (Pragmatic preclinical data science)
AI for Precision Medicine (Pragmatic preclinical data science)
Recently uploaded
Describing and Interpreting an Immersive Learning Case with the Immersion Cub...
Current descriptions of immersive learning cases are often difficult or impossible to compare. This is due to a myriad of different options on what details to include, which aspects are relevant, and on the descriptive approaches employed. Also, these aspects often combine very specific details with more general guidelines or indicate intents and rationales without clarifying their implementation. In this paper we provide a method to describe immersive learning cases that is structured to enable comparisons, yet flexible enough to allow researchers and practitioners to decide which aspects to include. This method leverages a taxonomy that classifies educational aspects at three levels (uses, practices, and strategies) and then utilizes two frameworks, the Immersive Learning Brain and the Immersion Cube, to enable a structured description and interpretation of immersive learning cases. The method is then demonstrated on a published immersive learning case on training for wind turbine maintenance using virtual reality. Applying the method results in a structured artifact, the Immersive Learning Case Sheet, that tags the case with its proximal uses, practices, and strategies, and refines the free text case description to ensure that matching details are included. This contribution is thus a case description method in support of future comparative research of immersive learning cases. We then discuss how the resulting description and interpretation can be leveraged to change immersion learning cases, by enriching them (considering low-effort changes or additions) or innovating (exploring more challenging avenues of transformation). The method holds significant promise to support better-grounded research in immersive learning.
快速办理(UAM毕业证书)马德里自治大学毕业证学位证一模一样
学校原件一模一样【微信：741003700 】《(UAM毕业证书)马德里自治大学毕业证学位证》【微信：741003700 】学位证，留信认证（真实可查，永久存档）原件一模一样纸张工艺/offer、雅思、外壳等材料/诚信可靠,可直接看成品样本，帮您解决无法毕业带来的各种难题！外壳，原版制作，诚信可靠，可直接看成品样本。行业标杆！精益求精，诚心合作，真诚制作！多年品质 ,按需精细制作，24小时接单,全套进口原装设备。十五年致力于帮助留学生解决难题，包您满意。
本公司拥有海外各大学样板无数，能完美还原。
1:1完美还原海外各大学毕业材料上的工艺：水印，阴影底纹，钢印LOGO烫金烫银，LOGO烫金烫银复合重叠。文字图案浮雕、激光镭射、紫外荧光、温感、复印防伪等防伪工艺。材料咨询办理、认证咨询办理请加学历顾问Q/微741003700
【主营项目】
一.毕业证【q微741003700】成绩单、使馆认证、教育部认证、雅思托福成绩单、学生卡等！
二.真实使馆公证(即留学回国人员证明,不成功不收费)
三.真实教育部学历学位认证（教育部存档！教育部留服网站永久可查）
四.办理各国各大学文凭(一对一专业服务,可全程监控跟踪进度)
如果您处于以下几种情况：
◇在校期间，因各种原因未能顺利毕业……拿不到官方毕业证【q/微741003700】
◇面对父母的压力，希望尽快拿到；
◇不清楚认证流程以及材料该如何准备；
◇回国时间很长，忘记办理；
◇回国马上就要找工作，办给用人单位看；
◇企事业单位必须要求办理的
◇需要报考公务员、购买免税车、落转户口
◇申请留学生创业基金
留信网认证的作用:
1:该专业认证可证明留学生真实身份
2:同时对留学生所学专业登记给予评定
3:国家专业人才认证中心颁发入库证书
4:这个认证书并且可以归档倒地方
5:凡事获得留信网入网的信息将会逐步更新到个人身份内，将在公安局网内查询个人身份证信息后，同步读取人才网入库信息
6:个人职称评审加20分
7:个人信誉贷款加10分
8:在国家人才网主办的国家网络招聘大会中纳入资料，供国家高端企业选择人才
Mending Clothing to Support Sustainable Fashion_CIMaR 2024.pdf
Ozturkcan, S., Berndt, A., & Angelakis, A. (2024). Mending clothing to support sustainable fashion. Presented at the 31st Annual Conference by the Consortium for International Marketing Research (CIMaR), 10-13 Jun 2024, University of Gävle, Sweden.
Authoring a personal GPT for your research and practice: How we created the Q...
Thematic analysis in qualitative research is a time-consuming and systematic task, typically done using teams. Team members must ground their activities on common understandings of the major concepts underlying the thematic analysis, and define criteria for its development. However, conceptual misunderstandings, equivocations, and lack of adherence to criteria are challenges to the quality and speed of this process. Given the distributed and uncertain nature of this process, we wondered if the tasks in thematic analysis could be supported by readily available artificial intelligence chatbots. Our early efforts point to potential benefits: not just saving time in the coding process but better adherence to criteria and grounding, by increasing triangulation between humans and artificial intelligence. This tutorial will provide a description and demonstration of the process we followed, as two academic researchers, to develop a custom ChatGPT to assist with qualitative coding in the thematic data analysis process of immersive learning accounts in a survey of the academic literature: QUAL-E Immersive Learning Thematic Analysis Helper. In the hands-on time, participants will try out QUAL-E and develop their ideas for their own qualitative coding ChatGPT. Participants that have the paid ChatGPT Plus subscription can create a draft of their assistants. The organizers will provide course materials and slide deck that participants will be able to utilize to continue development of their custom GPT. The paid subscription to ChatGPT Plus is not required to participate in this workshop, just for trying out personal GPTs during it.
Farming systems analysis: what have we learnt?.pptx
Presentation given at the official farewell of Prof Ken Gillet at Wageningen on 13 June 2024
11.1 Role of physical biological in deterioration of grains.pdf
Storagedeteriorationisanyformoflossinquantityandqualityofbio-materials.
Themajorcausesofdeteriorationinstorage
•Physical
•Biological
•Mechanical
•Chemical
Storageonlypreservesquality.Itneverimprovesquality.
Itisadvisabletostartstoragewithqualityfoodproduct.Productwithinitialpoorqualityquicklydepreciates
8.Isolation of pure cultures and preservation of cultures.pdf
Isolation of pure culture, its various method.
在线办理(salfor毕业证书)索尔福德大学毕业证毕业完成信一模一样
学校原件一模一样【微信：741003700 】《(salfor毕业证书)索尔福德大学毕业证》【微信：741003700 】学位证，留信认证（真实可查，永久存档）原件一模一样纸张工艺/offer、雅思、外壳等材料/诚信可靠,可直接看成品样本，帮您解决无法毕业带来的各种难题！外壳，原版制作，诚信可靠，可直接看成品样本。行业标杆！精益求精，诚心合作，真诚制作！多年品质 ,按需精细制作，24小时接单,全套进口原装设备。十五年致力于帮助留学生解决难题，包您满意。
本公司拥有海外各大学样板无数，能完美还原。
1:1完美还原海外各大学毕业材料上的工艺：水印，阴影底纹，钢印LOGO烫金烫银，LOGO烫金烫银复合重叠。文字图案浮雕、激光镭射、紫外荧光、温感、复印防伪等防伪工艺。材料咨询办理、认证咨询办理请加学历顾问Q/微741003700
【主营项目】
一.毕业证【q微741003700】成绩单、使馆认证、教育部认证、雅思托福成绩单、学生卡等！
二.真实使馆公证(即留学回国人员证明,不成功不收费)
三.真实教育部学历学位认证（教育部存档！教育部留服网站永久可查）
四.办理各国各大学文凭(一对一专业服务,可全程监控跟踪进度)
如果您处于以下几种情况：
◇在校期间，因各种原因未能顺利毕业……拿不到官方毕业证【q/微741003700】
◇面对父母的压力，希望尽快拿到；
◇不清楚认证流程以及材料该如何准备；
◇回国时间很长，忘记办理；
◇回国马上就要找工作，办给用人单位看；
◇企事业单位必须要求办理的
◇需要报考公务员、购买免税车、落转户口
◇申请留学生创业基金
留信网认证的作用:
1:该专业认证可证明留学生真实身份
2:同时对留学生所学专业登记给予评定
3:国家专业人才认证中心颁发入库证书
4:这个认证书并且可以归档倒地方
5:凡事获得留信网入网的信息将会逐步更新到个人身份内，将在公安局网内查询个人身份证信息后，同步读取人才网入库信息
6:个人职称评审加20分
7:个人信誉贷款加10分
8:在国家人才网主办的国家网络招聘大会中纳入资料，供国家高端企业选择人才
ESA/ACT Science Coffee: Diego Blas - Gravitational wave detection with orbita...
ESA/ACT Science Coffee: Diego Blas - Gravitational wave detection with orbita...Advanced-Concepts-Team
Presentation in the Science Coffee of the Advanced Concepts Team of the European Space Agency on the 07.06.2024.
Speaker: Diego Blas (IFAE/ICREA)
Title: Gravitational wave detection with orbital motion of Moon and artificial
Abstract:
In this talk I will describe some recent ideas to find gravitational waves from supermassive black holes or of primordial origin by studying their secular effect on the orbital motion of the Moon or satellites that are laser ranged.Applied Science: Thermodynamics, Laws & Methodology.pdf
When I was asked to give a companion lecture in support of ‘The Philosophy of Science’ (https://shorturl.at/4pUXz) I decided not to walk through the detail of the many methodologies in order of use. Instead, I chose to employ a long standing, and ongoing, scientific development as an exemplar. And so, I chose the ever evolving story of Thermodynamics as a scientific investigation at its best.
Conducted over a period of >200 years, Thermodynamics R&D, and application, benefitted from the highest levels of professionalism, collaboration, and technical thoroughness. New layers of application, methodology, and practice were made possible by the progressive advance of technology. In turn, this has seen measurement and modelling accuracy continually improved at a micro and macro level.
Perhaps most importantly, Thermodynamics rapidly became a primary tool in the advance of applied science/engineering/technology, spanning micro-tech, to aerospace and cosmology. I can think of no better a story to illustrate the breadth of scientific methodologies and applications at their best.
ESR spectroscopy in liquid food and beverages.pptx
With increasing population, people need to rely on packaged food stuffs. Packaging of food materials requires the preservation of food. There are various methods for the treatment of food to preserve them and irradiation treatment of food is one of them. It is the most common and the most harmless method for the food preservation as it does not alter the necessary micronutrients of food materials. Although irradiated food doesn’t cause any harm to the human health but still the quality assessment of food is required to provide consumers with necessary information about the food. ESR spectroscopy is the most sophisticated way to investigate the quality of the food and the free radicals induced during the processing of the food. ESR spin trapping technique is useful for the detection of highly unstable radicals in the food. The antioxidant capability of liquid food and beverages in mainly performed by spin trapping technique.
Sexuality - Issues, Attitude and Behaviour - Applied Social Psychology - Psyc...
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...
Context. With a mass exceeding several 104 M⊙ and a rich and dense population of massive stars, supermassive young star clusters
represent the most massive star-forming environment that is dominated by the feedback from massive stars and gravitational interactions
among stars.
Aims. In this paper we present the Extended Westerlund 1 and 2 Open Clusters Survey (EWOCS) project, which aims to investigate
the influence of the starburst environment on the formation of stars and planets, and on the evolution of both low and high mass stars.
The primary targets of this project are Westerlund 1 and 2, the closest supermassive star clusters to the Sun.
Methods. The project is based primarily on recent observations conducted with the Chandra and JWST observatories. Specifically,
the Chandra survey of Westerlund 1 consists of 36 new ACIS-I observations, nearly co-pointed, for a total exposure time of 1 Msec.
Additionally, we included 8 archival Chandra/ACIS-S observations. This paper presents the resulting catalog of X-ray sources within
and around Westerlund 1. Sources were detected by combining various existing methods, and photon extraction and source validation
were carried out using the ACIS-Extract software.
Results. The EWOCS X-ray catalog comprises 5963 validated sources out of the 9420 initially provided to ACIS-Extract, reaching a
photon flux threshold of approximately 2 × 10−8 photons cm−2
s
−1
. The X-ray sources exhibit a highly concentrated spatial distribution,
with 1075 sources located within the central 1 arcmin. We have successfully detected X-ray emissions from 126 out of the 166 known
massive stars of the cluster, and we have collected over 71 000 photons from the magnetar CXO J164710.20-455217.
Recently uploaded (20)
GBSN - Biochemistry (Unit 6) Chemistry of Proteins
GBSN - Biochemistry (Unit 6) Chemistry of Proteins
Describing and Interpreting an Immersive Learning Case with the Immersion Cub...
Describing and Interpreting an Immersive Learning Case with the Immersion Cub...
Mending Clothing to Support Sustainable Fashion_CIMaR 2024.pdf
Mending Clothing to Support Sustainable Fashion_CIMaR 2024.pdf
Authoring a personal GPT for your research and practice: How we created the Q...
Authoring a personal GPT for your research and practice: How we created the Q...
aziz sancar nobel prize winner: from mardin to nobel
aziz sancar nobel prize winner: from mardin to nobel
Farming systems analysis: what have we learnt?.pptx
Farming systems analysis: what have we learnt?.pptx
11.1 Role of physical biological in deterioration of grains.pdf
11.1 Role of physical biological in deterioration of grains.pdf
Basics of crystallography, crystal systems, classes and different forms
Basics of crystallography, crystal systems, classes and different forms
8.Isolation of pure cultures and preservation of cultures.pdf
8.Isolation of pure cultures and preservation of cultures.pdf
ESA/ACT Science Coffee: Diego Blas - Gravitational wave detection with orbita...
ESA/ACT Science Coffee: Diego Blas - Gravitational wave detection with orbita...
Applied Science: Thermodynamics, Laws & Methodology.pdf
Applied Science: Thermodynamics, Laws & Methodology.pdf
ESR spectroscopy in liquid food and beverages.pptx
ESR spectroscopy in liquid food and beverages.pptx
Sexuality - Issues, Attitude and Behaviour - Applied Social Psychology - Psyc...
Sexuality - Issues, Attitude and Behaviour - Applied Social Psychology - Psyc...
EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...
EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...
Patient subtypes: real or not?
- 1. Patient subtypes: real or not? (Clustering, you’re doing it wrong) Paul Agapow Data Science Institute <p.agapow@ic.ac.uk> @agapow March 2018
- 3. Patient assignment is a clustering problem Precision medicine (assign patients to clusters) Translational medicine (infer clusters from patients)
- 4. Clustering requires many decisions • Similarity • Group boundaries • Spectra • Ground truth • Noise / non-clustered • Resolution / cut-offs • Uninteresting clusters • Stable & robust
- 5. So are clusters real? Every dataset contains clusters, with different set of clusters being revealed by different methods, but not all of these clusters are real or interesting or meaningful. (Paraphrased from Christian Hennig)
- 6. Example: Diabetes • 6 clinical vars produce 5 clusters • Validated in other datasets
- 7. But! After van Smeden, Harrel, Dahly: • Dimension reduce 6 to 5 only? • 2 related random vars can generate 6 “clusters” • Not validated in other data types
- 8. Example: Asthma • Complex & heterogeneous • Many attempts to stratify: 3, 4, 6+ clusters
- 9. Are asthma clusters real? • Use multiple methods & multiple datasets to validate • Compare nested clusters with homogeneity & completeness
- 10. Are all asthma clusters equally real? • Requires many more genes to id TAC3a & b than 1 or 2 • Because different clusters cluster differently
- 11. Biclustering • Better approach? • Simultaneously group samples & features • Relieves assumption of clustering everything
- 12. Take home • There are many ways to cluster & thus many clusters • Lots of different ways to be a cluster, even in same dataset • Too easy to fish • Validate with other data types
- 13. Or ... Clustering methods are hypothesis generators, cluster partitions are hypotheses and need to be validated or proven to be useful.
- 14. Thanks • Nazanin Kermani • Mansoor Saqi • Axel Oehmichen